Literature DB >> 27543830

Impact of major depressive disorder, distinct subtypes, and symptom severity on lifestyle in the BiDirect Study.

Corinna Rahe1, Laura Khil2, Jürgen Wellmann2, Bernhard T Baune3, Volker Arolt4, Klaus Berger5.   

Abstract

The aim of this study was to examine associations of major depressive disorder (MDD), its distinct subtypes, and symptom severity with the individual lifestyle factors smoking, diet quality, physical activity, and body mass index as well as with a combined lifestyle index measuring the co-occurrence of these lifestyle factors. A sample of 823 patients with MDD and 597 non-depressed controls was examined. The psychiatric assessment was based on a clinical interview including the Mini International Neuropsychiatric Interview and the Hamilton Depression Rating Scale. Each lifestyle factor was scored as either healthy or unhealthy, and the number of unhealthy lifestyle factors was added up in a combined lifestyle index. Cross-sectional analyses were performed using alternating logistic regression and ordinal logistic regression, adjusted for socio-demographic characteristics. After adjustment, MDD was significantly associated with smoking, low physical activity, and overweight. Likewise, MDD was significantly related to the overall lifestyle index. When stratifying for subtypes, all subtypes showed higher odds for an overall unhealthier lifestyle than controls, but the associations with the individual lifestyle factors were partly different. Symptom severity was associated with the lifestyle index in a dose-response manner. In conclusion, patients with MDD represent an important target group for lifestyle interventions.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atypical depression; Cardiovascular risk factors; Health behavior; Lifestyle; Melancholic depression; Subtypes of depression; Unipolar depression

Mesh:

Year:  2016        PMID: 27543830     DOI: 10.1016/j.psychres.2016.08.035

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

1.  Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial.

Authors:  Ella J Daly; Jaskaran B Singh; Maggie Fedgchin; Kimberly Cooper; Pilar Lim; Richard C Shelton; Michael E Thase; Andrew Winokur; Luc Van Nueten; Husseini Manji; Wayne C Drevets
Journal:  JAMA Psychiatry       Date:  2018-02-01       Impact factor: 21.596

2.  Efficacy of the Whole-Body Cryotherapy as Add-on Therapy to Pharmacological Treatment of Depression-A Randomized Controlled Trial.

Authors:  Joanna Rymaszewska; Katarzyna M Lion; Lilla Pawlik-Sobecka; Tomasz Pawłowski; Dorota Szcześniak; Elżbieta Trypka; Julia E Rymaszewska; Agnieszka Zabłocka; Bartlomiej Stanczykiewicz
Journal:  Front Psychiatry       Date:  2020-06-09       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.